17 Subject taking one of the following medications influencing the central nervous system within four weeks prior to trial entry neuroleptics monoamine oxidase MAO inhibitors anxiolytics amphetamines sedative antihistamines tranquilizers hypnotics narcotic analgesics except for medication taken as epileptic treatment 